ABOUT US
Based in New York City, Lexeo is a clinical stage genetic medicine company dedicated to reshaping heart health by applying pioneering science to fundamentally change how cardiovascular diseases are treated.
By taking aim at the underlying genetic cause of the devastating diseases we target, we seek to create substantial positive impact and reduce the overwhelming burdens placed on people receiving treatment, their caregivers, and healthcare systems.
Le MISSION
Our mission is to transform healthcare by pushing boundaries in developing meaningful genetic medicines for diseases, regardless of prevalence.
Our vision is a world where genetic medicines resolve the burden of disease, transforming all aspects of society.
xeo VISION
